Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 3, 2002, Pages 787-796

  Emerson, Lyndal R ^a   Nau, Martin E ^a   Martin, Rodger K ^a   Kyle, Dennis E ^a   Vahey, Maryanne ^a   Wirth, Dyann F ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CARRIER PROTEIN; CHLOROQUINE; DNA BINDING PROTEIN; FERRIC CHLORIDE; FERRIC CHLORIDE FE 55; FUNGAL PROTEIN; IRON; IRON 55; PROTEIN AFT1; UNCLASSIFIED DRUG;

ARN2 GENE; ARN4 GENE; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; FET3 GENE; FET4 GENE; FUNGAL GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SIT1 GENE; SMF2 GENE;

ANTIMALARIALS; BLOTTING, NORTHERN; CARRIER PROTEINS; CHLOROQUINE; COMPUTATIONAL BIOLOGY; CULTURE MEDIA; IRON; IRON RADIOISOTOPES; KINETICS; MEMBRANE TRANSPORT PROTEINS; PHOSPHOPROTEIN PHOSPHATASE; RNA, FUNGAL; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIDEROPHORES;

EID: 0036174441     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.3.787-796.2002     Document Type: Article

References (63)

1. The iron environment in heme and heme-antimalarial complexes of pharmacological interest
2. High-resolution autoradiography of malarial parasites treated with 3 H-chloroquine
3. DNA: Reaction with chloroquine
4. The effect of lysosomotrophic bases and inhibitors of transglutaminase on iron uptake by immature erythroid cells
5. The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake
6. Transferrin receptors and transferrin iron uptake by cultured human blood monocytes
7. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum
8. Making malaria-treatment policy in the face of drug resistance
9. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens
10. Accessing genetic information with high-density DNA arrays
11. Inhibition of DNA and RNA polymerase reactions by chloroquine
12. Endonuclease IV (nfo) mutant of Escherichia coli
13. Ferric reductase of Saccharomyces cerevisiae: Molecular characterization, role in iron uptake, and transcriptional control by iron
14. Molecular characterization of a copper transport protein in S. cerevisiae: An unexpected role for copper in iron transport
15. Lysosomotropic agents
16. Identification of Saccharomyces cerevisiae genes conferring resistance to quinoline ring-containing antimalarial drugs
17. Regulation of iron uptake in Saccharomyces cerevisiae. The ferrireductase and Fe(II) transporter are regulated independently
18. Increased dosage of a transcriptional activator gene enhances iron-limited growth of Saccharomyces cerevisiae
19. Kinetics and thermodynamics of chloroquine and hydroxychloroquine transport across the human erythrocyte membrane
20. Quinoline antimalarials: Mechanisms of action and resistance and prospects for new agents
21. Iron metabolism of established human hematopoietic cell lines in vitro
22. Growth of Francisella tularensis LVS in macrophages: The acidic intracellular compartment provides essential iron required for growth
23. Mitochondria of mammalian Plasmodium spp
24. Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates - A possible mechanism of their anti-malarial effect?
25. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells
26. Iron chelation therapy for malaria
27. The kinetics of transferrin endocytosis and iron uptake from transferrin in rabbit reticulocytes
28. Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells
29. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
30. Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages
31. Siderophore uptake and use by the yeast Saccharomyces cerevisiae
32. Siderophore-mediated iron uptake in Saccharomyces cerevisiae: The SIT1 gene encodes a ferrioxamine B permease that belongs to the major facilitator superfamily
33. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials
34. Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators
35. Clinical studies of iron chelators in malaria
36. Contribution of base excision repair, nucleotide excision repair, and DNA recombination to alkylation resistance of the fission yeast Schizosaccharomyces pombe
37. Deferoxamine effects on Plasmodium falciparum gene expression
38. Technical assessment of the Affymetrix yeast expression Gene-Chip YE6100 platform in a heterologous model of genes that confer resistance to antimalarial drugs in yeast
39. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis
40. Transferrin protein and iron uptake by cultured rat fibroblasts
41. The interaction of chloroquine with nucleic acids and nucleoproteins
42. Phenotypic reversal of the btn1 defects in yeast by chloroquine: A yeast model for Batten disease
43. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism
44. PlasmoDB. An integrative database of the Plasmodium falciparum genome. Tools for accessing and analyzing finished and unfinished sequence data
45. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron
46. Hemoglobin catabolism and iron utilization by malaria parasites
47. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmoium falciparum: A target for antimalarial therapy
48. Malaria: The effect of iron and chloroquine on the erythrocytic forms of Plasmodium berghei
49. Iron chelating agents for treating malaria
50. De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite
51. Chloroquine reduces neuronal and glial iron uptake
52. Identification of differentially transcribed RNA and DNA helicase-related genes of Plasmodium falciparum
53. Deferoxamine: Stimulation of hematin polymerization and antagonism of its inhibition by chloroquine
54. Structural specificity of chloroquine-hematin binding related to inhibition of hematin polymerization and parasite growth
55. Chloroquine and the fungal phagosome
56. Biochemistry of iron uptake
57. Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum
58. Genome-wide expression monitoring in Saccharomyces cerevisiae
59. Bark, weeds, and iron chelators-drugs for malaria
60. Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast
61. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine
62. The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake